Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses

The approval of the first oncolytic virus for the treatment of metastatic melanoma and the compiling evidence that the use of oncolytic viruses can enhance cancer immunotherapies targeted against various immune checkpoint proteins has attracted great interest in the field of cancer virotherapy. We h...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Erkko Ylösmäki, Cristina Malorzo, Cristian Capasso, Oona Honkasalo, Manlio Fusciello, Beatriz Martins, Leena Ylösmäki, Antti Louna, Sara Feola, Henrik Paavilainen, Karita Peltonen, Veijo Hukkanen, Tapani Viitala, Vincenzo Cerullo
Format: Artigo
Langue:anglais
Publié: 2018
Accès en ligne:https://doi.org/10.1016/j.ymthe.2018.06.008
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!